atropine has been researched along with Amyloid Neuropathy Type 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, D; Delahaye, N; Delforge, J; Dinanian, S; Dollé, F; Le Guludec, D; Merlet, P; Mzabi, H; Samuel, D; Sarda, L; Slama, MS; Syrota, A | 1 |
1 trial(s) available for atropine and Amyloid Neuropathy Type 1
Article | Year |
---|---|
Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Amyloid Neuropathies, Familial; Atropine; Blood Pressure; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Epinephrine; Female; Heart; Heart Rate; Heart Ventricles; Humans; Isoproterenol; Male; Middle Aged; Myocardium; Norepinephrine; Radionuclide Imaging; Receptors, Muscarinic; Sympathomimetics | 2001 |